Medications prescribed to asthmatic children: an historical cohort study comparing clinical practice with NIH...

Area of Science:

• Pediatric Pulmonology
• Pharmacotherapy
• Healthcare Management

Background:

• National Institutes of Health (NIH) guidelines advocate for inhaled corticosteroids or other anti-inflammatory agents for persistent moderate to severe childhood asthma.
• Effective asthma management in children relies on adherence to evidence-based treatment protocols.
• Understanding the prevalence of preventive medication prescribing is crucial for assessing guideline implementation.

Purpose of the Study:

• To evaluate the implementation of NIH guidelines for childhood asthma treatment.
• To determine the prevalence of prescribing preventive anti-inflammatory medication for pediatric asthma patients.
• To identify factors associated with the prescription of preventive asthma medications.

Main Methods:

• A non-concurrent cohort study involving 311 children aged 2 to 19 years with asthma.
• Data collected from nine Medicaid managed care plans in the northeastern USA between January and December 1994.
• Logistic regression analysis was used to identify associations between patient characteristics and medication prescribing.

Main Results:

• Preventive medications were prescribed to 61.1% of children with moderate or severe asthma and 27.1% with mild asthma.
• Prescribing preventive medication was significantly associated with moderate/severe asthma (aOR 5.34) and age 5-19 years (aOR 2.11).
• A prior emergency department visit was also associated with prescribing preventive medication (aOR 2.27).

Conclusions:

• NIH asthma treatment guidelines were not consistently implemented for all children with moderate to severe asthma during the study period.
• Prescribing preventive medications was linked to specific clinical indicators like disease severity and prior emergency care.
• Further efforts are needed to ensure optimal adherence to evidence-based guidelines for pediatric asthma management.